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Abstract
© 2016, Springer Science+Business Media New York.Nephropatia epidemica (NE), a mild form
of hemorrhagic fever with renal syndrome (HFRS), is an endemic zoonosis in the Republic of
Tatarstan, Russia. Humans become infected by inhaling an aerosol contaminated with Puumala
virus, a member of genus Hantavirus. NE diagnosis is based on detection of anti-hantavirus
antibodies using ELISA. Antibodies to hantavirus nucleocapsid (N) protein are detected early in
the course of infection, suggesting that this viral protein is the most immunogenic. Several
epitopes were previously identified on N protein as well as glycoproteins of Puumala viruses
endemic  in  Europe.  However,  there  is  limited  knowledge  about  Puumala  virus  N
protein antigenic epitopes in NE patients in the Republic of Tatarstan. The aim of the present
study is  to  identify  N protein  and glycoprotein  epitopes  which induce a  humoral  immune
response in  NE cases.  Analysis  of  NE serum using an array of  overlapping N protein and
glycoprotein peptides identified the most immunogenic epitopes, which can then be used for
developing Puumala virus-specific vaccine.
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